MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Prelude Therapeutics Incorporated

PRLD

#2987
Prelude Therapeutics Incorporated
2.76
-5.80%
Sector:
Base:
Profit Currency:
Daily Range
2.76
2.76
Year Range
0.61
4.19
Daily Change
-5.80%
Monthly Change
+28.37%
6 month change
+113.95%
Year Change
+253.85%
Previous Close
2.93
Open
2.76
Bid
Ask
Low
2.76
High
2.76
Volume
3
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. PRLD
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Investing Investing
INCY PRLD
2026.02.04
Prelude Therapeutics stock gets reiterated Market Outperform rating at Citizens
Investing Investing
PRLD
2026.02.03
Prelude Therapeutics stock surges after FDA clears IND for cancer drug
Seeking Alpha Seeking Alpha
INCY ABVX MDGL ALKS IMTX
2025.12.16
Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)
Investing Investing
PRLD
2025.12.08
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Zacks Zacks
GS-PA M AMGN MMM WDC
2025.11.24
Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus
Investing Investing
INCY PRLD
2025.11.14
Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens
Investing Investing
PRLD
2025.11.12
Earnings call transcript: Prelude Therapeutics Q3 2025 sees stock steadiness
Investing Investing
TRV MRK HD CAT NVDA
2025.11.04
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.56%
Investing Investing
CAT ORCL NVDA LUMN MU
2025.11.04
Palantir, Shopify among market cap stock movers on Tuesday
Investing Investing
EXPD WAT LUMN MU UNM
2025.11.04
Palantir, Uber among market cap stock movers on Tuesday
Investing Investing
INCY PRLD
2025.11.04
Prelude Therapeutics stock climbs after exclusive JAK2 option deal with Incyte
Investing Investing
PRLD
2025.11.04
Prelude Therapeutics shifts focus to JAK2 and KAT6A programs

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd